FDA Puts Plans to Test LSD in Anxiety Patients in Study on Hold

The US Food and Drug Administration put a clinical hold on Mind Medicine Inc's application to start testing the psychedelic drug commonly known as LSD in patients with generalized anxiety disorder.
Reuters Health Information

source https://www.medscape.com/viewarticle/965285?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension